US Map / Virginia
State VA

Clinical Trials in Virginia

Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.

Total Trials
267
Recruiting Now
267
← Back to US Map
Top Conditions in Virginia
NSCLC (7)Advanced Solid Tumor (6)Breast Cancer (6)Heart Failure (5)Ovarian Cancer (5)Non-small Cell Lung Cancer (5)Endometrial Cancer (5)Acute Myeloid Leukemia (4)Non-Small Cell Lung Cancer (4)Proteinuric Kidney Disease (3)Advanced Solid Tumors (3)Colorectal Neoplasms (3)
NCT07446855 Phase 1, Phase 2
Recruiting
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Pa...
Condition
Solid Tumours
Enrollment
180 pts
Location
United States, Australia, Japan
Sponsor
AstraZeneca
View Trial →
NCT06874335 Phase 1
Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
95 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
View Trial →
NCT05723198 Phase 3
Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Year...
Condition
Areata Alopecia
Enrollment
595 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT04715178 N/A
Recruiting
Beat Childhood Cancer Specimen Banking and Data Registry
Condition
Pediatric Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Giselle Sholler
View Trial →
NCT07095452 Phase 2, Phase 3
Recruiting
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous...
Condition
Multiple Myeloma
Enrollment
660 pts
Location
United States, France, Japan
Sponsor
AbbVie
View Trial →
NCT06633016 Phase 2
Recruiting
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPL...
Condition
Major Depressive Disorder
Enrollment
230 pts
Location
United States
Sponsor
Autobahn Therapeutics, Inc.
View Trial →
NCT04372615 Phase 2
Recruiting
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Condition
Autoimmune Encephalitis
Enrollment
116 pts
Location
United States, Netherlands, Spain
Sponsor
University of Utah
View Trial →
NCT05426967 N/A
Recruiting
rTMS for Military TBI-related Depression
Condition
Depressive Symptoms
Enrollment
198 pts
Location
United States
Sponsor
Henry M. Jackson Foundation fo
View Trial →
NCT05519293 Phase 1, Phase 2
Recruiting
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation
Condition
Non-small Cell Lung Cancer
Enrollment
76 pts
Location
United States
Sponsor
RedCloud Bio
View Trial →
NCT06346600 N/A
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients Wit...
Condition
Neovascular (Wet) Age-related Macular Degeneration
Enrollment
83 pts
Location
United States, China
Sponsor
Skyline Therapeutics
View Trial →
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
View Trial →
NCT05211895 Phase 3
Recruiting
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Conc...
Condition
Non-Small Cell Lung Cancer
Enrollment
860 pts
Location
United States, Belgium, Brazil
Sponsor
AstraZeneca
View Trial →
NCT04671667 Phase 2
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itse...
Condition
Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment
188 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06979453 Phase 3
Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BM...
Condition
Plaque Psoriasis
Enrollment
366 pts
Location
United States, Argentina, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06324357 Phase 1, Phase 2
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in...
Condition
Metastatic Breast Cancer
Enrollment
768 pts
Location
United States, Belgium, China
Sponsor
Boehringer Ingelheim
View Trial →
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06043817 Phase 1, Phase 2
Recruiting
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or...
Condition
Non-Small Cell Lung Cancer
Enrollment
251 pts
Location
United States, France, Germany
Sponsor
Pierre Fabre Medicament
View Trial →
NCT07222917 Phase 2
Recruiting
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Ba...
Condition
Chronic Kidney Disease and Hypertension
Enrollment
218 pts
Location
United States, Argentina, Bulgaria
Sponsor
AstraZeneca
View Trial →
NCT06053255 N/A
Recruiting
Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroilii...
Condition
Sacroiliitis
Enrollment
10 pts
Location
United States
Sponsor
FUSMobile Inc.
View Trial →
NCT07054073 N/A
Recruiting
HCMR Re-Imaging Study
Condition
Hypertrophic Cardiomyopathy (HCM)
Enrollment
314 pts
Location
United States, United Kingdom
Sponsor
Christopher Kramer
View Trial →
NCT06486454 N/A
Recruiting
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tu...
Condition
Liver Neoplasms
Enrollment
5,000 pts
Location
United States
Sponsor
HistoSonics, Inc.
View Trial →
NCT03754114 N/A
Recruiting
Brain Oxygen Optimization in Severe TBI, Phase 3
Condition
Brain Injuries, Traumatic
Enrollment
1,094 pts
Location
United States, Canada
Sponsor
University of Michigan
View Trial →
NCT06857955 Phase 2
Recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive P...
Condition
Hypertension
Enrollment
380 pts
Location
United States, Japan, Singapore
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06805825 Phase 1
Recruiting
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or...
Condition
Gastrointestinal Stromal Tumors
Enrollment
67 pts
Location
United States
Sponsor
Novelty Nobility, Inc.
View Trial →
NCT07009860 Phase 2
Recruiting
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide...
Condition
Alcohol Liver Disease
Enrollment
100 pts
Location
United States, Puerto Rico
Sponsor
Altimmune, Inc.
View Trial →
Page 8 of 11 — 267 trials total
← Prev Next →